Established in 2008, Avadim Technologies, Inc is a Life Sciences company pioneering pathogenesis-based treatments through scientific and medical research by engaging with leading hospitals, scientists, athlete healthcare professionals, physicians and researchers.
Our platform of therapies work to protect and encourage natural physiological functions of the outer barrier of the body. Topical acidic therapy supports an intact permeability barrier needed for overall health.
We are committed to ensuring the quality and safety of our products as well as delivering the best possible health and wellness outcomes for patients, clinicians and athletes worldwide. [pH]UEL 5.0™ is produced in an FDA Regulatory & Compliant drug and medical device certified manufacturing facility in the United States. [pH]UEL 5.0™ is non-toxic and indicated for daily use.
Sign up to get the latest on new product and collection releases, philanthropy events, stories, and more!